新型汉防己甲素衍生物的合成及其生物活性

以汉防己甲素为原料,经溴代反应制得关键中间体5-溴汉防己甲素(2); 2与硼酸衍生物经Suzuki反应合成了6个新型的汉防己甲素衍生物(4a~4f),其结构经¹H NMR, ¹³C NMR和ESI-MS表征。采用CCK-8法初步考察了4a~4f对人早幼粒白血病细胞(HL60)和人肺癌细胞(A549)的抑制活性;并采用MTT法对活性较好的化合物进行复筛。采用酶联免疫吸附法考察4a~4f对多种受体酪氨酸激酶的抑制活性。结果表明：4b, 4c和4e对HL60和A549有一定的抑制活性; 4b和4c对受体酪氨酸激酶FGFR1的抑制活性大于50%。     

含苯并咪唑和异噁唑结构席夫碱的合成及其抑菌活性

根据活性亚结构拼接原理,以取代苯甲醛、盐酸羟胺、N-氯代丁二酰亚胺和2-苯并咪唑基乙腈等为原料,经肟化、氯代、环化及缩合反应,合成了一系列新型的含苯并咪唑和异噁唑结构的席夫碱化合物(5a~5h),收率60%~75%,其结构经~1H NMR,~(13)C NMR,IR和HR-MS表征。采用菌丝生长速率法测试了化合物对番茄灰霉菌和生菜菌核菌的抑菌活性。结果表明:在用药量为100μg·m ~(-1)时,苯环上含有氟原子或甲氧基的席夫碱(5c,5d和5e)对生菜菌核菌显示出较好的活性,抑制率为71.3%~76.1%。     

柔弱短指软珊瑚Sinularia Tenella Li. 中西松烯二萜内酯成分 研究

首次报道柔弱短指软珊瑚(SinulariatenellaLi.)的化学成分。从中国南海采集的柔弱短指软珊瑚中分离得到5个西松烯二萜内酯。根据波谱数据分析,推导出它们的结构：dihydroflexibilide(1),flxibilide(2)sinulariolide(3),(1R,4R,5R,8S,9S,12S,13S)-9-acetoxy-5,8:12,13-diepoxy-cembr-15(17)-en-16,4(olide(4)和(1R,4R,5S12S,13S)-5-acetoxy-12,13-epoxy-cembr-8E,15(17)-dien-16,3-olide(5)。还利用1^H-1^HCOSY,HMQC,HBMC二维谱首次对dihydroflexibilide(1)所有的1^HNMR和13^CNMR信号归属作了指定。测定了1、2和3的细胞毒性。     

Synthesis and antibacterial activities of pleuromutilin derivatives

Six new pleuromutilin derivatives were designed and synthesized, confirmed by MS, IR and 1H NMR techniques. And the antibacterial activities were primarily evaluated in vitro. The results indicated that most of the derivatives showed more potent activities against corresponding bacterial strains than that of pleuromutilin. Especially, compounds 4d and 5b had obvious activities against salmonella compared with pleuromutifin.     

Synthesis and Antifungal Activities of Novel Strobilurin Derivatives Containing Quinolin-2(1H)-one Moiety

To discover novel lead compounds with better antifungal activities, a series of novel strobilurin derivatives containing quinolin-2(1H)-one moiety was designed and synthesized via intermediate derivatization method. Their structures were characterized by means of ¹H nuclear magnetic resonance(¹H NMR), ¹³C NMR and high resolution mass spectrometry(HRMS). The biological assay results indicate that most target compounds exhibit good to excellent fungicidal activities against 10 plant pathogens. Compounds 4d, 5b and 5c possess 94.1%, 83.8% and 80.9% in vitro inhibition respectively against Rhizotonia cereals at the concentration of 50 μg/mL, which are better than that of the control agents. Especially, the inhibition activities of compound 4d against all of the tested fungi approach or exceed those of the controls. The structure-activity relationship was also discussed.     

氟代索拉非尼的合成及其抗肿瘤活性研究

以N-甲基-4-氯-2-吡啶甲酰胺为原料,经过4步共合成4个化合物(S-1,S-2,R-1和R-2),其中2个为新的化合物(S-1和R-2)。经过1H NMR,13C NMR,HR-MS等方法对其结构表征。最后通过CTG法,测试4种化合物对四种人肝癌细胞(PLC/PRF/5,Hep3B,HepG2,BEL-7402)的抑制活性。结果表明:S-1,S-2,R-1和R-2均表现较明显的对4种细胞的抑制活性,且呈现出浓度依赖关系。IC50值从1304nM到11228nM。其中化合物R-1(瑞格非尼)对PLC/PRF/5和HepG2细胞,S-1对Hep3B细胞的抑制活性,R-2对HepG2的细胞活性均较高于原药索拉非尼。     

香豆素席夫碱衍生物的合成及抗肿瘤活性研究

设计合成了18个未见文献报道的含席夫碱结构的香豆素衍生物,其结构经1H NMR,13C NMR,ESI-MS和元素分析确证.体外对人口腔鳞癌细胞KB及多药耐药株KBv200的初步毒性试验表明,化合物4a,4b,5b,3d和4d具有中等的抗肿瘤活性,并对其构效关系进行了讨论.     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

新型桃金娘烯醛基双酰胺-噻二唑化合物的合成及其抗真菌活性

以α-蒎烯为起始原料,经氧化制得桃金娘烯酸（3）;脂肪族二酸在POCl₃作用下与氨基硫脲经脱水环合制得脂肪族双噻二唑（4a~4h）; 4a~4h分别与3经脱水反应合成了8个新型的桃金娘烯醛基双酰胺噻二唑化合物（5a~5h）,其结构经¹H NMR, ¹³C NMR, IR和ESI-MS表征。抗真菌活性测试结果表明,在用药量为50 μg·mL^-1时,5a~5h对黄瓜枯萎病菌、花生褐斑病菌、苹果轮纹病菌、番茄早疫病菌和小麦赤霉病菌均有一定的抑制作用,其中桃金娘烯醛-辛二酸基双酰胺-噻二唑(5f)对苹果轮纹病菌的抑制率为60.3%,桃金娘烯醛-丁二酸基双酰胺-噻二唑(5b)和桃金娘烯醛-癸二酸基双酰胺-噻二唑(5h)对小麦赤霉病菌的抑制率分别为52.8%和54.4%。     

氮杂香豆雌酚衍生物的合成及其抗肿瘤活性

以间苯二甲醚为原料, 经碘代、偶联、胺解、分子内环化及脱甲醚环化共5步反应,合成9个氮杂香豆雌酚衍生物（6a~6i）, 其结构经¹H NMR, ¹³C NMR 和APCI-MS表征。采用MTT法研究了6对Hela、 SKOV3、 BEL-7404、 HepG2及A-549等癌细胞的体外生长抑制活性。结果表明：6h对SKOV3细胞的生长抑制活性最高,其IC₅₀值为81.58 μmol·L^-1。     

6-氯-4-哌嗪基喹唑啉缩氨基硫脲类化合物的合成及体外抗肿瘤活性

以5-氯-2-氨基苯甲酸和甲酰胺为起始原料,经环化、氯化、取代和缩合反应,合成了3个未见文献报道的含哌嗪的喹唑啉衍生物5a~5c。 其结构用1H NMR、13C NMR、ESI-MS及IR测试技术进行了表征。 采用MTT法测试了化合物5a~5c对人胃癌SGC-7901、人口腔表皮样癌KB和人纤维肉瘤HT-1080的体外抗肿瘤活性。 结果表明,化合物5a~5c对人胃癌SGC-7901和人纤维肉瘤HT-1080有弱的抑制活性,而对人口腔表皮样癌KB无明显抑制活性。     

5-O-三苯硅基-4＂-O-酰基阿维菌素B1a的合成和生物活性

酯化;5-O-三苯硅基-4＂-O-酰基阿维菌素B1a的合成和生物活性     

Design,Synthesis and Insecticidal Activities of Novel 5-Alkoxyfuran-2(5H)-one Derivatives

A series of novel 5?alkoxyfuran-2(5H)-one derivatives was synthesized, and characterized by 1H NMR, 13C NMR and HRMS. Biological activities of all the title compounds were evaluated systematically. Preliminary bioassays indicated that most of the compounds exhibited moderate insecticidal activities against Aphis craccivora and Nilaparvata lugens at 100 mg/L. Compounds 4h and 4w exhibited 100% mortality rate against Aphis craccivora at 100 mg/L, and compound 4h exhibited good mortality rate against Aphis craccivora and Nilaparvata lugens (60% and 75%, respectively) even at 4 mg/L. The results demonstrated the impact of various chemical groups on insecticidal activities and provided a potential clue for further exploring novel high-effective broad-spectrum insecticides.     

新型含5-芳基异噁唑结构的氰基丙烯酸酯类化合物的合成及生物活性

通过5-取代苯基异噁唑-3-甲基胺与2-氰基-3,3-二甲硫基丙烯酸取代酯的缩合反应,合成了一系列含5-取代苯基异噁唑环结构的氰基丙烯酸酯类衍生物,并采用核磁共振波谱和元素分析对化合物的结构进行了表征.初步的生物活性测试结果表明,部分化合物显示出较好的除草活性,在1500 g/ha剂量下,化合物7h,7i和7m对芥菜的茎叶处理抑制率分别为90%,40%和100%;化合物7m和7n对繁缕的茎叶处理抑制率分别为100%和80%;化合物7m和7n对小藜的茎叶处理抑制率分别为100%和85%.此外,化合物7b和7c还表现出良好的抗肿瘤活性,其对HepG2细胞的IC50值分别为3.2和10.1μmol/L.     

Design,Synthesis and Biological Activities of Novel N-Aryl-1H-pyrazole-5-carboxylate Derivatives

In an attempt to search for potent fungicide, a series of novel N-aryl-1H-pyrazole-5-carboxylate derivatives was designed and synthesized. Their chemical structures were characterized by ¹H NMR spectra and high resolution mass spectrometry(HRMS). The preliminary bioassay results indicated that some target compounds displayed better fungicidal activities against certain fungi at 50 μg/mL or favorable antitumor activities at 5 μg/mLcompared with chlorothalonil and 5-fluorouracil, respectively. The structure-activity relationship demonstrated that the introduction of ester group and amide bond was favorable to the improvement of activities against Physalospora piricola and Phytophthora capsici.     

Synthesis,antimicrobial and anti-inflammatory activities of some novel 5-substituted imidazolone analogs

In view of potent antimicrobial and anti-inflammatory activities exhibited by 5-substituted imidazolones, a variety of novel imidazolone analogs 3a-l were synthesized by the condensation of different substituted oxazolones 1 with various aromatic amines 2. All the synthesized compounds were screened for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Several analogs produced good or moderate activities particularly against the tested Gram-positive bacteria Micrococcus luteus and Gram-negative bacteria Pseudomonas aeruginosa and. Meanwhile, compounds 3b and 3c displayed marked antifungal activity against C. albicans. In addition, the in vivo anti-inflammatory activity of the synthesized compounds was determined using the carrageenin-induced paw oedema method in rats. Two of 5-substituted imidazolone derivatives, 3k and 3d show good anti-inflammatory activity. The structures of all the newly synthesized compounds were elucidated using IR, ¹H NMR and ¹³C NMR.     

Design and Synthesis of 3-Substituedmethylenethiochroman-4-ones as Anticancer Agents

A series of 3-substituedmethylenethiochroman-4-ones was designed and synthesized, and their structures were confirmed by 1H NMR, 13C NMR, MS, IR, UV and elemental analysis. The results of their anticancer activity studies show that almost all 3-chloromethylenethiochroman-4-ones exhibit high anticancer activities and their activities are all better than reference cisplatin. Their IC50 against cancer cells is in a range of 0.80―9.17 μg/mL. Thus they could be promising candidates for anticancer drugs. However, compound 5 has no activity against cancer cells, thus chloromethylene at the 3 position of thiochroman-4-ones seems to play an important role in observed anticancer activities.     

1/2,5-二取代吲唑-3-甲酰胺衍生物的合成及其抗肿瘤活性

以吲唑-3-羧酸为原料,依次经溴代和酯化反应制得中间体5-溴吲唑-3-羧酸甲酯(2);2经N-烷基化并原位水解生成1/2-取代-5-溴吲唑-3-羧酸(3);3与吡啶酮甲胺类化合物经缩合反应制得酰胺(4);4与芳基频哪醇硼酸酯发生Suzuki偶联反应合成了14个新型二取代吲唑-3-甲酰吡啶酮甲胺衍生物(5a~5n),收率26%~32%,其结构经~1H NMR,~(13)C NMR和HR-MS(ESI-TOF)表征。通过NOE差谱确证了取代基在吲唑氮原子上的取代位置。采用MTT法研究了5a~5n对人B淋巴瘤细胞(Ramos)、人黑色素瘤细胞(CHL-1,WM-266-4)和乳腺癌细胞(BT-474)的体外抗肿瘤活性。结果表明:5a,5b,5m对Ramos细胞、5a,5b,5l对WM-266-4细胞、5a,5b,5d,5e,5h,5j,5m,5n对CHL-1细胞和5a,5b,5d,5h,5m对BT-474细胞具有较好的抑制活性(IC5010.0μmol.L-1)。     

大黄酸-缬氨酸加合物的合成及初步抗肿瘤活性

以大黄酸为原料,经酯化、烷基化、水解及缩合等反应步骤合成了12个大黄酸-缬氨酸加合物.目标化合物经1H NMR,~(13)C NMR和HRMS进行了结构确证.以顺铂和阿霉素为阳性对照药,采用四甲基偶氮唑盐(MTT)法考察了目标化合物的体外抗肿瘤(Hela,MCF-7,HepG2,KB和HEK293T等5株细胞)活性.结果表明,化合物5l显示出较好的抗肿瘤活性,其IC50值在1.6~9.4μmol/L之间.作用机制研究结果表明,化合物5l能够与DNA发生较强的结合作用.     

Design,synthesis, and characterization of some new benzimidazole derivatives and biological evaluation

A new series of benzimidazole derivatives ( 1-15 ) containing 1,2,4-triazole, 1,3,4-thiadiazole, 1,3,4-oxadiazole, and thiazolidinon rings have been synthesized. All new synthesized benzimidazole compounds were confirmed by ¹H NMR, ¹³C NMR spectra, and LC-MS, and they were examined for their antioxidant and antimicrobial activities. Compounds 7 and 1 showed the highest and the lowest antioxidant activities, respectively. The lowest minimum inhibition concentration value found in compound 5 against Enterobacter aerogenes.